Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FV865
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,491
Award facts
- Contract value 100% obligated
- $58,491.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $58,491.18 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under an existing indefinite delivery vehicle and is scheduled for completion by January 29, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. (doing business as AmerisourceBergen) ultimately responsible for contract performance. Repatha is a PCSK9 inhibitor indicated for cholesterol management in eligible military beneficiaries and veterans.
This delivery order falls under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs. The DLA Medical Supply Chain utilizes this prime vendor contract to efficiently procure a broad range of pharmaceutical products and medical supplies for Defense Health Agency customers, the U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains established capabilities to fulfill federal medical procurement requirements through open competition, with a demonstrated track record of delivering specialty medications and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FV865?
SPE2DR26FV865 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FV865 worth?
The government has obligated $58,491 on SPE2DR26FV865.
Is contract SPE2DR26FV865 an order under another contract?
Yes. SPE2DR26FV865 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV865 competed?
The extent of competition for SPE2DR26FV865 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award